As shown in Fig. 6C, increased NF-κB activity was induced in TLR7/8-expressing cells stimulated with COVID-19 patient–derived EVs, compared to those treated with HC subject–derived EVs (P < 0.005). Here, NFKB1 is linked to COVID-19.